Cargando…
PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation
Phosphorylation is a recently established cause of phosphatase and tensin homolog (PTEN) gene inactivation, which leads to defect tumour-suppressor function. In pancreatic cancer, this phenomenon has not been reported. Based on database and clinical sample analyses, we found that PTEN phosphorylatio...
Autores principales: | Ma, Qiang, Wu, Xiuxiu, Wu, Jing, Wu, Huanwen, Xiao, Ying, Wang, Lili, Liang, Zhiyong, Liu, Tonghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641177/ https://www.ncbi.nlm.nih.gov/pubmed/29069834 http://dx.doi.org/10.18632/oncotarget.20552 |
Ejemplares similares
-
Retraction: PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation
por: Ma, Qiang, et al.
Publicado: (2018) -
Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines
por: Huanwen, Wu, et al.
Publicado: (2009) -
SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis
por: Ma, Qiang, et al.
Publicado: (2017) -
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Wang, Lili, et al.
Publicado: (2017) -
PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay
por: Liang, Xiaolong, et al.
Publicado: (2018)